Bank of Montreal’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,718
| Closed | -$13K | – | 4551 |
|
|
2019
Q1 | $13K | Buy |
2,718
+2,339
| +617% | +$11.2K | ﹤0.01% | 3406 |
|
|
2018
Q4 | $1K | Sell |
379
-85,107
| -100% | -$225K | ﹤0.01% | 4252 |
|
|
2018
Q3 | $862K | Sell |
85,486
-81,705
| -49% | -$824K | ﹤0.01% | 1870 |
|
|
2018
Q2 | $1.21M | Buy |
167,191
+1,191
| +0.7% | +$8.62K | ﹤0.01% | 1729 |
|
|
2018
Q1 | $1M | Buy |
166,000
+95,884
| +137% | +$579K | ﹤0.01% | 1782 |
|
|
2017
Q4 | $674K | Buy |
70,116
+4,616
| +7% | +$44.4K | ﹤0.01% | 1946 |
|
|
2017
Q3 | $582K | Sell |
65,500
-5,804
| -8% | -$51.6K | ﹤0.01% | 2040 |
|
|
2017
Q2 | $902K | Buy |
71,304
+50,492
| +243% | +$639K | ﹤0.01% | 1862 |
|
|
2017
Q1 | $219K | Buy |
20,812
+14,212
| +215% | +$150K | ﹤0.01% | 2217 |
|
|
2016
Q4 | $78K | Sell |
6,600
-26,770
| -80% | -$316K | ﹤0.01% | 2674 |
|
|
2016
Q3 | $393K | Buy |
33,370
+9,896
| +42% | +$117K | ﹤0.01% | 1980 |
|
|
2016
Q2 | $304K | Sell |
23,474
-106,511
| -82% | -$1.38M | ﹤0.01% | 2068 |
|
|
2016
Q1 | $2.08M | Buy |
129,985
+63,339
| +95% | +$1.01M | ﹤0.01% | 1337 |
|
|
2015
Q4 | $1.91M | Buy |
66,646
+5,733
| +9% | +$164K | ﹤0.01% | 1347 |
|
|
2015
Q3 | $1.73M | Buy |
60,913
+1,133
| +2% | +$32.3K | ﹤0.01% | 1252 |
|
|
2015
Q2 | $2.15M | Buy |
59,780
+3,832
| +7% | +$138K | ﹤0.01% | 1253 |
|
|
2015
Q1 | $1.63M | Sell |
55,948
-1,158
| -2% | -$33.7K | ﹤0.01% | 1324 |
|
|
2014
Q4 | $1.2M | Buy |
57,106
+11,870
| +26% | +$250K | ﹤0.01% | 1378 |
|
|
2014
Q3 | $877K | Sell |
45,236
-504
| -1% | -$9.77K | ﹤0.01% | 1495 |
|
|
2014
Q2 | $714K | Buy |
45,740
+33,702
| +280% | +$526K | ﹤0.01% | 1583 |
|
|
2014
Q1 | $249K | Buy |
12,038
+3,038
| +34% | +$62.8K | ﹤0.01% | 1947 |
|
|
2013
Q4 | $116K | Hold |
9,000
| – | – | ﹤0.01% | 2173 |
|
|
2013
Q3 | $105K | Hold |
9,000
| – | – | ﹤0.01% | 2116 |
|
|
2013
Q2 | $42K | Buy |
+9,000
| New | +$42K | ﹤0.01% | 2411 |
|